Cargando…

Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy

Chimeric antigen receptor T cell (CAR-T) therapy to hematological malignancies has demonstrated tremendous clinical outcomes. However, the therapeutic efficacy of CAR-T cells in solid tumors remains limited due to the scarcity of tumor-specific antigen targets and the poor infiltration of CAR-T cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ren-Yu, Wei, Ding, Liu, Ze-Kun, Yong, Yu-Le, Wei, Wei, Zhang, Zhi-Yun, Lv, Jian-Jun, Zhang, Zhao, Chen, Zhi-Nan, Bian, Huijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798074/ https://www.ncbi.nlm.nih.gov/pubmed/31681766 http://dx.doi.org/10.3389/fcell.2019.00233

Ejemplares similares

Blockade of Macrophage CD147 Protects Against Foam Cell Formation in Atherosclerosis
por: Lv, Jian-Jun, et al.
Publicado: (2021)

Deficiency of CD147 Attenuated Non-alcoholic Steatohepatitis Progression in an NLRP3-Dependent Manner
por: Zhang, Tian, et al.
Publicado: (2020)

Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
por: Tseng, Hsiang-chi, et al.
Publicado: (2020)

Basolateral CD147 induces hepatocyte polarity loss by E‐cadherin ubiquitination and degradation in hepatocellular carcinoma progress
por: Lu, Meng, et al.
Publicado: (2018)

System analysis of the regulation of the immune response by CD147 and FOXC1 in cancer cell lines
por: Shang, Yu-Kui, et al.
Publicado: (2018)

Chimeric antigen receptor T cells targeting CD147 for non-small cell lung cancer therapy
por: Chen, Xiao-Hong, et al.
Publicado: (2021)

Humanized CD30-Targeted Chimeric Antigen Receptor T Cells Exhibit Potent Preclinical Activity Against Hodgkin’s Lymphoma Cells
por: Guo, Jing, et al.
Publicado: (2022)

Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 to Eradicate Acute Myeloid Leukemia
por: Yu, Wei, et al.
Publicado: (2022)

Detachment Activated CyPA/CD147 Induces Cancer Stem Cell Potential in Non-stem Breast Cancer Cells
por: Meng, Yao, et al.
Publicado: (2020)

Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinoma
por: Wu, Jiao, et al.
Publicado: (2014)

CD147 Promotes CXCL1 Expression and Modulates Liver Fibrogenesis
por: Shi, Wen-Pu, et al.
Publicado: (2018)

CD147 promotes collective invasion through cathepsin B in hepatocellular carcinoma
por: Wang, Shi-Jie, et al.
Publicado: (2020)

CD147 functions as the signaling receptor for extracellular divalent copper in hepatocellular carcinoma cells
por: Ding, Pengfei, et al.
Publicado: (2017)

Active demethylation upregulates CD147 expression promoting non-small cell lung cancer invasion and metastasis
por: Liao, Cheng-Gong, et al.
Publicado: (2022)

Activation of TGF-β1-CD147 positive feedback loop in hepatic stellate cells promotes liver fibrosis
por: Li, Hai-Yan, et al.
Publicado: (2015)

Purification of a polyclonal antibody against CD147 for ELISA using antigen-immunoaffinity chromatography
por: Liu, Shuangshuang, et al.
Publicado: (2017)

Identification of crucial genes based on expression profiles of hepatocellular carcinomas by bioinformatics analysis
por: Liu, Ze-Kun, et al.
Publicado: (2019)

Novel chimeric antigen receptor T cell-based immunotherapy: a perspective for triple-negative breast cancer
por: Geng, Peizhen, et al.
Publicado: (2023)

Role of Integrin αvβ3 in Doxycycline-Induced Anti-Proliferation in Breast Cancer Cells
por: Chen, Yi-Fong, et al.
Publicado: (2022)

Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma
por: Song, Ze-Bing, et al.
Publicado: (2021)

Urea as a By-Product of Ammonia Metabolism Can Be a Potential Serum Biomarker of Hepatocellular Carcinoma
por: Bai, Changsen, et al.
Publicado: (2021)

SARS-CoV-2 Employ BSG/CD147 and ACE2 Receptors to Directly Infect Human Induced Pluripotent Stem Cell-Derived Kidney Podocytes
por: Kalejaiye, Titilola D., et al.
Publicado: (2022)

CD8(+) chimeric antigen receptor T cells manufactured in absence of CD4(+) cells exhibit hypofunctional phenotype
por: Lee, Sang Yun, et al.
Publicado: (2023)

Identification of PANoptosis-relevant subgroups to evaluate the prognosis and immune landscape of patients with liver hepatocellular carcinoma
por: Zhang, Zhengwei, et al.
Publicado: (2023)

CD147 blockade as a potential and novel treatment of graft rejection
por: Luan, Jing, et al.
Publicado: (2017)

CD147 reinforces [Ca(2+)](i) oscillations and promotes oncogenic progression in hepatocellular carcinoma
por: Tang, Juan, et al.
Publicado: (2015)

Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas
por: Chu, Fuliang, et al.
Publicado: (2023)

Role of CD147 in the development and diagnosis of hepatocellular carcinoma
por: Huang, Defa, et al.
Publicado: (2023)

Endothelial genetic deletion of CD147 induces changes in the dual function of the blood‐brain barrier and is implicated in Alzheimer’s disease
por: Wang, Hao, et al.
Publicado: (2021)

Involvement of HAb18G/CD147 in T cell activation and immunological synapse formation
por: Hu, Jinsong, et al.
Publicado: (2010)

Systems analysis of key genes and pathways in the progression of hepatocellular carcinoma
por: Shang, Yu-Kui, et al.
Publicado: (2018)

Identification of Potential Antigens for Developing mRNA Vaccine for Immunologically Cold Mesothelioma
por: Zhang, Shichao, et al.
Publicado: (2022)

Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma
por: Kong, Ling-Min, et al.
Publicado: (2011)

CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis
por: Wu, Jiao, et al.
Publicado: (2022)

Guidelines for Regulated Cell Death Assays: A Systematic Summary, A Categorical Comparison, A Prospective
por: Hu, Xi-min, et al.
Publicado: (2021)

Targeting CD147 for T to NK Lineage Reprogramming and Tumor Therapy
por: Geng, Jie-Jie, et al.
Publicado: (2017)

A novel prognostic prediction model of cuprotosis-related genes signature in hepatocellular carcinoma
por: Shao, Ruo-Nan, et al.
Publicado: (2023)

CD38 Causes Autophagic Flux Inhibition and Cardiac Dysfunction Through a Transcriptional Inhibition Pathway Under Hypoxia/Ischemia Conditions
por: Zhang, Xingyue, et al.
Publicado: (2020)

CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment
por: Zhang, Yinjiang, et al.
Publicado: (2021)

Sirtuin 5 is Dispensable for CD8(+) T Cell Effector and Memory Differentiation
por: Duan, Qianqian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0gfuc4df7auceeene4svroe188